Cardiac mapping is a technique in which the information from cardiac electrograms is gathered and displayed. Cardiac mapping is used to diagnose the heart rhythms especially in case of arrhythmia. The cardiac mapping procedure is usually done by inserting catheter into the heart chamber percutaneously and recording the electrograms sequentially, this is done in order to correlate the electrograms with cardiac anatomy. The new 3D cardiac mapping systems create the three dimensional model of any chamber of heart and can track exact location of the catheter. This allows movement of the catheters without using X-ray. They are designed to improve the resolution and gain prompt cardiac activation maps.
The 3D cardiac mapping system market is anticipated to grow with a significant CAGR owing to the increase in number of patients with arrhythmia and other cardiac disorders, rising pressure to reduce diagnosis errors and increasing healthcare expenditure. The major factors driving the growth of 3D cardiac mapping systems is the precision and patient safety enabled by real-time monitoring. The increase in aging population who are more prone to chronic heart disorders will elevate the demand for the 3D cardiac mapping system. The increase in prevalence and diagnosis rate of cardiac illness is the major factors which is creating the demand for 3D cardiac mapping systems. The 3D cardiac mapping also help in reducing the time of diagnosis. The restraining factors for the 3D cardiac mapping system market are high cost of services and limited adoption rate of the systems.
The global 3D cardiac mapping system market are classified on the basis of technology, end use and geography.
Based on the technology, the global 3D cardiac mapping system market is divided into following:
- Electroanatomical mapping
- Basket Catheter mapping
- Real-time positional management (Cardiac Pathways) EP system
Based on end user, the global 3D cardiac mapping system market is divided into following:
- Diagnostic Centers
The awareness of 3D cardiac mapping system is giving rise to the adoption of the systems. The elimination of errors in diagnosis helps the physician in providing better treatment and cure. The adoption rate of 3D cardiac mapping system by the hospitals is high as compared to that of independent clinics and is estimated to be the fastest growing segment. Electroanatomical mapping are used widely as it hold the potential to increase the safety, efficacy and efficiency of catheter. Real-time positional management (Cardiac Pathways) EP system contribute maximum share in the overall 3D cardiac mapping systems during the forecast period.
On the basis of geography, the global 3D cardiac mapping system market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America contributes maximum share to the 3D cardiac mapping system market. European countries are expected to represent significant growth rates due to the growing healthcare practices. Amongst the Asian countries, India and China are more promising due to large population pool, increased prevalence of cardiac diseases, increasing awareness, rapid improvement in healthcare services with the saturation in the developed markets.
For more info (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/toc/11383
Some of the key players in 3D cardiac mapping system market are Biosense Webster, Inc., St. Jude Medical and Boston Scientific Corporation, Inc. The companies are majorly focusing in the improvement of services provided to customers with the new techniques that provide the physicians in better and quick diagnosis.